“…77,78 Cav-1-deficent fibroblasts and hydrogen peroxide treated fibroblasts also share the same proteomic profile, with the upregulation of myofibroblast markers, glycolytic enzymes and anti-oxidant proteins. 22,74,[78][79][80] Consistent with these findings, a loss of stromal Cav-1 is a powerful biomarker for a lethal tumor microenvironment, in breast and prostate cancers. 37,[81][82][83][84][85][86][87][88][89] More specifically, in breast cancer patients, a loss of stromal Cav-1 is associated with early conditions, most of the DNA damage occurs in the cancer-associated fibroblasts, as the MCF7 cancer cells effectively mount an anti-oxidant defense by upregulating key proteins, such as peroxiredoxin-1 and TIGAR.…”